Patients treated with pembrolizumab plus paclitaxel with or without bevacizumab had a statistically significant and clinically meaningful improvement in PFS, regardless of PD-L1 status. Topline ...
Add Yahoo as a preferred source to see more of our stories on Google. Exclusive: Rivian CEO on how its Uber deal came together, and why the AI 'driver' is the future of mobility Everything you need to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results